Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by IceColdBeeron Nov 25, 2020 11:06am
181 Views
Post# 31969578

RE:RE:$RVV $RVVTF - Cilinicaltrails - Updated today

RE:RE:$RVV $RVVTF - Cilinicaltrails - Updated today
First off my man, they can't and won't do that, as it is considered too promotional by the FDA.  Last thing they want to do is get on their bad side.  That goes for all companies and not just RVV.

Second, much of that buying came from the US because they do pay attention to that and the further we get along, the higher we will see the share price rise.  Thus the high volume yesterday.  This will continue to happen, the further we get along in the process.

Third, the news that came out didn't hurt, as you know the Shroom sector is really heating up.  All in all, RVV is starting to look much better and I believe we will be in the high .30's or low .40's by Christmas.  If they get approval in 2021, I believe this stock is about $2.00, not the $5.00 or $10.00 some have spoken about.

All in all, the trading of the stock and slow increase in share price looks great.



1ottrunner wrote: Imagine, actual progress and management couldn't be bothered to drop press on clinical updates.

idiots


<< Previous
Bullboard Posts
Next >>